XML Financial LLC decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 11.6% in the third quarter, HoldingsChannel reports. The fund owned 2,447 shares of the financial services provider’s stock after selling 320 shares during the quarter. XML Financial LLC’s holdings in iShares Biotechnology ETF were worth $356,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently bought and sold shares of the stock. Jane Street Group LLC bought a new position in shares of iShares Biotechnology ETF in the first quarter worth approximately $14,386,000. Cetera Investment Advisers increased its stake in iShares Biotechnology ETF by 689.4% in the 1st quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock worth $12,498,000 after buying an additional 79,541 shares in the last quarter. State of Michigan Retirement System raised its holdings in iShares Biotechnology ETF by 150.0% during the second quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock valued at $17,158,000 after acquiring an additional 75,000 shares during the period. Aristides Capital LLC purchased a new position in shares of iShares Biotechnology ETF in the second quarter valued at about $9,180,000. Finally, Sanctuary Advisors LLC bought a new position in shares of iShares Biotechnology ETF in the second quarter worth about $8,118,000. 62.45% of the stock is owned by institutional investors.
iShares Biotechnology ETF Price Performance
NASDAQ IBB opened at $148.85 on Monday. iShares Biotechnology ETF has a 12 month low of $113.56 and a 12 month high of $150.57. The stock’s 50 day moving average is $144.84 and its 200 day moving average is $141.27.
iShares Biotechnology ETF Dividend Announcement
iShares Biotechnology ETF Company Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
See Also
- Five stocks we like better than iShares Biotechnology ETF
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- California Resources Stock Could Be a Huge Long-Term Winner
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- What is Insider Trading? What You Can Learn from Insider Trading
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.